177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for mHSPC

NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL

Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients

ADT with PORT is a good treatment option for men with unfavourable intermediate risk or favourable high risk PC

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression

Understanding Zimbabwe's pharmacovigilance system

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Intraoperative radiotherapy: The Medical City experience

Understanding AL amyloidosis: Treatment and diagnosis

Addressing challenges in palliative care